approach bridges the health gap in situations where vaccines may not be available or fully effective. With a team led by President and CEO Chris Wagner and Dr. Vernon Oi, ImmunoFlex is committed to delivering solutions that support immune health for life. Their work includes analyzing the number and type of proteins in the blood to measure immune responses and exploring the role of cannabinoids/cannabimimetics in immune cell binding.